{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:43:17Z","timestamp":1790800997683,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control viral replication. However, natural virological suppression and absence of immune dysfunction are not always long-term sustained. We define exceptional EC (EEC) as HIV-1 subjects who maintain the EC characteristics without disease progression for more than 25 years. We analyzed three EEC, diagnosed between 1988 and 1992, who never showed signs of clinical disease progression in absence of any antiretroviral treatment. A comprehensive clinical, virological, and immunological study was performed. The individuals simultaneously exhibited \u22653 described host protective alleles, low levels of total HIV-1 DNA (&lt;20 copies\/10<jats:sup>6<\/jats:sup> CD4<jats:sup>+<\/jats:sup> T-cells) without evidence of replication-competent viruses (&lt;0.025 IUPM), consistent with high levels of defective genomes, strong cellular HIV-1-specific immune response, and a high poly-functionality index (&gt;0.50). Inflammation levels of EEC were similar to HIV-1 negative donors. Remarkably, they showed an exceptional lack of viral evolution and 8-fold lower genetic diversity (&lt;0.01\u2009s\/n) in <jats:italic>env<\/jats:italic> gene than other EC. We postulate that these EEC represent cases of spontaneous functional HIV-1 cure. A non-functional and non-genetically evolving viral reservoir along with an HIV-1-specific immune response seems to be key for the spontaneous functional cure.<\/jats:p>","DOI":"10.1038\/s41598-020-58696-y","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T11:03:18Z","timestamp":1580900598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure"],"prefix":"10.1038","volume":"10","author":[{"given":"Concepcion","family":"Casado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pernas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tarancon-Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Sanchez-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"De Pablo-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Merino-Mansilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Del Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Lorenzo-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilio","family":"Lopez-Galindez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"58696_CR1","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","volume":"212","author":"AM Crooks","year":"2015","unstructured":"Crooks, A. M. et al. Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. J. Infect. Dis. 212, 1361\u20131365, https:\/\/doi.org\/10.1093\/infdis\/jiv218 (2015).","journal-title":"J. Infect. Dis."},{"key":"58696_CR2","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.1128\/JVI.00308-07","volume":"81","author":"A Finzi","year":"2007","unstructured":"Finzi, A., Orthwein, A., Mercier, J. & Cohen, E. A. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol. 81, 7476\u20137490 (2007).","journal-title":"J. Virol."},{"key":"58696_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.1165706","volume":"323","author":"DD Richman","year":"2009","unstructured":"Richman, D. D. et al. The challenge of finding a cure for HIV infection. Sci. 323, 1304\u20131307 (2009).","journal-title":"Sci."},{"key":"58696_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","volume":"568","author":"RK Gupta","year":"2019","unstructured":"Gupta, R. K. et al. HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation. Nat. 568, 244\u2013248, https:\/\/doi.org\/10.1038\/s41586-019-1027-4 (2019).","journal-title":"Nat."},{"key":"58696_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G Hutter","year":"2009","unstructured":"Hutter, G. et al. Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692\u2013698, https:\/\/doi.org\/10.1056\/NEJMoa0802905 (2009).","journal-title":"N. Engl. J. Med."},{"key":"58696_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41577-018-0085-4","volume":"19","author":"MP Davenport","year":"2019","unstructured":"Davenport, M. P. et al. Functional cure of HIV: the scale of the challenge. Nat. Rev. 19, 45\u201354, https:\/\/doi.org\/10.1038\/s41577-018-0085-4 (2019).","journal-title":"Nat. Rev."},{"key":"58696_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/COH.0b013e328345a328","volume":"6","author":"B Autran","year":"2011","unstructured":"Autran, B., Descours, B., Avettand-Fenoel, V. & Rouzioux, C. Elite controllers as a model of functional cure. Curr. Opin. HIV. AIDS 6, 181\u2013187, https:\/\/doi.org\/10.1097\/COH.0b013e328345a328 (2011).","journal-title":"Curr. Opin. HIV. AIDS"},{"key":"58696_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2007.08.010","volume":"27","author":"SG Deeks","year":"2007","unstructured":"Deeks, S. G. & Walker, B. D. Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy. Immun. 27, 406\u2013416 (2007).","journal-title":"Immun."},{"key":"58696_CR9","doi-asserted-by":"publisher","first-page":"e11079","DOI":"10.1371\/journal.pone.0011079","volume":"5","author":"C Casado","year":"2010","unstructured":"Casado, C. et al. Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS One 5, e11079 (2010).","journal-title":"PLoS One"},{"key":"58696_CR10","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1128\/JVI.01805-17","volume":"92","author":"M Pernas","year":"2018","unstructured":"Pernas, M. et al. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection. J. Virol. 92, 1805\u20131817, https:\/\/doi.org\/10.1128\/JVI.01805-17 (2018).","journal-title":"J. Virol."},{"key":"58696_CR11","doi-asserted-by":"publisher","first-page":"ofx064","DOI":"10.1093\/ofid\/ofx064","volume":"4","author":"E Canoui","year":"2017","unstructured":"Canoui, E. et al. A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level. Open. forum Infect. Dis. 4, ofx064, https:\/\/doi.org\/10.1093\/ofid\/ofx064 (2017).","journal-title":"Open. forum Infect. Dis."},{"key":"58696_CR12","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1182\/blood-2011-10-381996","volume":"119","author":"D Mendoza","year":"2012","unstructured":"Mendoza, D. et al. Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood 119, 4645\u20134655 (2012).","journal-title":"Blood"},{"key":"58696_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7326\/M18-0759","volume":"169","author":"M Salgado","year":"2018","unstructured":"Salgado, M. et al. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant. Ann. Intern. Med. 169, 674\u2013683, https:\/\/doi.org\/10.7326\/M18-0759 (2018).","journal-title":"Ann. Intern. Med."},{"key":"58696_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcv.2011.04.012","volume":"52","author":"A Amendola","year":"2011","unstructured":"Amendola, A. et al. Standardization and performance evaluation of \u201cmodified\u201d and \u201cultrasensitive\u201d versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia. J. Clin. Virol. 52, 17\u201322, https:\/\/doi.org\/10.1016\/j.jcv.2011.04.012 (2011).","journal-title":"J. Clin. Virol."},{"key":"58696_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virol.2009.05.022","volume":"391","author":"V Sandonis","year":"2009","unstructured":"Sandonis, V. et al. A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs. Virology 391, 73\u201382 (2009).","journal-title":"Virology"},{"key":"58696_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho, Y. C. et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540\u2013551, https:\/\/doi.org\/10.1016\/j.cell.2013.09.020 (2013).","journal-title":"Cell"},{"key":"58696_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1099\/vir.0.19365-0","volume":"85","author":"G Bello","year":"2004","unstructured":"Bello, G. et al. Co-existence of recent and ancestral nucleotide sequences in viral quasispecies of human immunodeficiency virus type 1 patients. J. Gen. Virol. 85, 399\u2013407 (2004).","journal-title":"J. Gen. Virol."},{"key":"58696_CR18","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1128\/JVI.80.10.4758-4770.2006","volume":"80","author":"JR Bailey","year":"2006","unstructured":"Bailey, J. R. et al. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J. Virol. 80, 4758\u20134770 (2006).","journal-title":"J. Virol."},{"key":"58696_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00002030-199712000-00002","volume":"11","author":"P Lorenzi","year":"1997","unstructured":"Lorenzi, P. et al. Toxicity, efficacy, plasma drug concentrationsm and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. AIDS 11, 95\u201399 (1997).","journal-title":"AIDS"},{"key":"58696_CR20","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1128\/JVI.07034-11","volume":"86","author":"S Ferrando-Martinez","year":"2012","unstructured":"Ferrando-Martinez, S. et al. Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers. J. Virol. 86, 3667\u20133674, https:\/\/doi.org\/10.1128\/JVI.07034-11 (2012).","journal-title":"J. Virol."},{"key":"58696_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1160\/TH16-11-0867","volume":"117","author":"L Tarancon-Diez","year":"2017","unstructured":"Tarancon-Diez, L. et al. CCR5+ CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy. Thromb. Haemost. 117, 1141\u20131149, https:\/\/doi.org\/10.1160\/TH16-11-0867 (2017).","journal-title":"Thromb. Haemost."},{"key":"58696_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/gerona\/glv121","volume":"71","author":"RS de Pablo-Bernal","year":"2016","unstructured":"de Pablo-Bernal, R. S. et al. Monocyte Phenotype and Polyfunctionality Are Associated With Elevated Soluble Inflammatory Markers, Cytomegalovirus Infection, and Functional and Cognitive Decline in Elderly Adults. J. Gerontol. A Biol. Sci. Med. Sci 71, 610\u2013618, https:\/\/doi.org\/10.1093\/gerona\/glv121 (2016).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci"},{"key":"58696_CR23","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1128\/jvi.00049-16","volume":"90","author":"V Sanchez-Merino","year":"2016","unstructured":"Sanchez-Merino, V. et al. Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection. J. Virol. 90, 5231\u20135245, https:\/\/doi.org\/10.1128\/jvi.00049-16 (2016).","journal-title":"J. Virol."},{"key":"58696_CR24","doi-asserted-by":"publisher","first-page":"e42403","DOI":"10.1371\/journal.pone.0042403","volume":"7","author":"M Larsen","year":"2012","unstructured":"Larsen, M. et al. Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS One 7, e42403, https:\/\/doi.org\/10.1371\/journal.pone.0042403 (2012).","journal-title":"PLoS One"},{"key":"58696_CR25","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1195271","volume":"330","author":"F Pereyra","year":"2010","unstructured":"Pereyra, F. et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Sci. 330, 1551\u20131557 (2010).","journal-title":"Sci."},{"key":"58696_CR26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/infdis\/jiv521","volume":"213","author":"S Moron-Lopez","year":"2016","unstructured":"Moron-Lopez, S. et al. Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy. J. Infect. Dis. 213, 1008\u20131012, https:\/\/doi.org\/10.1093\/infdis\/jiv521 (2016).","journal-title":"J. Infect. Dis."},{"key":"58696_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1126\/science.7824947","volume":"267","author":"JM Coffin","year":"1995","unstructured":"Coffin, J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Sci. 267, 483\u2013489 (1995).","journal-title":"Sci."},{"key":"58696_CR28","doi-asserted-by":"publisher","first-page":"e1002251","DOI":"10.1371\/journal.pbio.1002251","volume":"13","author":"JM Cuevas","year":"2015","unstructured":"Cuevas, J. M., Geller, R., Garijo, R., Lopez-Aldeguer, J. & Sanjuan, R. Extremely High Mutation Rate of HIV-1 In Vivo. PLoS Biol. 13, e1002251, https:\/\/doi.org\/10.1371\/journal.pbio.1002251 (2015).","journal-title":"PLoS Biol."},{"key":"58696_CR29","doi-asserted-by":"publisher","first-page":"10402","DOI":"10.1128\/JVI.01223-10","volume":"84","author":"EY Kim","year":"2010","unstructured":"Kim, E. Y. et al. Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure. J. Virol. 84, 10402\u201310405 (2010).","journal-title":"J. Virol."},{"key":"58696_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1017\/s1355838201001881","volume":"7","author":"H Huthoff","year":"2001","unstructured":"Huthoff, H. & Berkhout, B. Two alternating structures of the HIV-1 leader RNA. RNA 7, 143\u2013157, https:\/\/doi.org\/10.1017\/s1355838201001881 (2001).","journal-title":"RNA"},{"key":"58696_CR31","doi-asserted-by":"publisher","unstructured":"Mueller, N., Das, A. T. & Berkhout, B. A Phylogenetic Survey on the Structure of the HIV-1 Leader RNA Domain That Encodes the Splice Donor Signal. Viruses 8, https:\/\/doi.org\/10.3390\/v8070200 (2016).","DOI":"10.3390\/v8070200"},{"key":"58696_CR32","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/cid\/ciw120","volume":"62","author":"B Dominguez-Molina","year":"2016","unstructured":"Dominguez-Molina, B. et al. Analysis of Non-AIDS-Defining Events in HIV Controllers. Clin. Infect. Dis. 62, 1304\u20131309, https:\/\/doi.org\/10.1093\/cid\/ciw120 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"58696_CR33","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/JVI.02165-06","volume":"81","author":"JN Blankson","year":"2007","unstructured":"Blankson, J. N. et al. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J. Virol. 81, 2508\u20132518 (2007).","journal-title":"J. Virol."},{"key":"58696_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1128\/JVI.01763-08","volume":"83","author":"H Hatano","year":"2009","unstructured":"Hatano, H. et al. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J. Virol. 83, 329\u2013335 (2009).","journal-title":"J. Virol."},{"key":"58696_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.1256304","volume":"345","author":"TA Wagner","year":"2014","unstructured":"Wagner, T. A. et al. HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Sci. 345, 570\u2013573, https:\/\/doi.org\/10.1126\/science.1256304 (2014).","journal-title":"Sci."},{"key":"58696_CR36","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.4156","volume":"22","author":"KM Bruner","year":"2016","unstructured":"Bruner, K. M. et al. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat. Med. 22, 1043\u20131049, https:\/\/doi.org\/10.1038\/nm.4156 (2016).","journal-title":"Nat. Med."},{"key":"58696_CR37","doi-asserted-by":"publisher","first-page":"9026","DOI":"10.1128\/JVI.79.14.9026-9037.2005","volume":"79","author":"B Joos","year":"2005","unstructured":"Joos, B. et al. Low Human Immunodeficiency Virus Envelope Diversity Correlates with Low In Vitro Replication Capacity and Predicts Spontaneous Control of Plasma Viremia after Treatment Interruptions. J. Virol. 79, 9026\u20139037 (2005).","journal-title":"J. Virol."},{"issue":"4","key":"58696_CR38","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1128\/JVI.73.4.2745-2751.1999","volume":"73","author":"E Yuste","year":"1999","unstructured":"Yuste, E., Sanchez-Palomino, S., Casado, C., Domingo, E. & Lopez-Galindez, C. Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events. J. Virol. 73(4), 2745\u20132751 (1999).","journal-title":"J. Virol."},{"key":"58696_CR39","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1128\/JVI.01254-10","volume":"85","author":"R Lorenzo-Redondo","year":"2011","unstructured":"Lorenzo-Redondo, R., Borderia, A. V. & Lopez-Galindez, C. Dynamics of HIV-1 \u201cin vitro\u201d fitness recovery. J. Virol. 85, 1861\u20131870 (2011).","journal-title":"J. Virol."},{"key":"58696_CR40","doi-asserted-by":"publisher","first-page":"e77663","DOI":"10.1371\/journal.pone.0077663","volume":"8","author":"C Casado","year":"2013","unstructured":"Casado, C. et al. Identification of a cluster of HIV-1 controllers infected with low replicating viruses. PLoS One 8, e77663, https:\/\/doi.org\/10.1371\/journal.pone.0077663 (2013).","journal-title":"PLoS One"},{"key":"58696_CR41","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1128\/mBio.02338-17","volume":"9","author":"C Casado","year":"2018","unstructured":"Casado, C. et al. Viral characteristics associated with the clinical nonprogressor phenotype are inherited by viruses from a cluster of HIV-1elite controllers. mBio 9, 2338\u20132317, https:\/\/doi.org\/10.1128\/mBio.02338-17 (2018).","journal-title":"mBio"},{"key":"58696_CR42","doi-asserted-by":"publisher","first-page":"e1000377","DOI":"10.1371\/journal.ppat.1000377","volume":"5","author":"KG Lassen","year":"2009","unstructured":"Lassen, K. G. et al. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog. 5, e1000377 (2009).","journal-title":"PLoS Pathog."},{"key":"58696_CR43","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1073\/pnas.1609057113","volume":"113","author":"H Imamichi","year":"2016","unstructured":"Imamichi, H. et al. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc. Natl Acad. Sci. USA 113, 8783\u20138788, https:\/\/doi.org\/10.1073\/pnas.1609057113 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58696_CR44","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1128\/JVI.02439-12","volume":"86","author":"RW Buckheit 3rd","year":"2012","unstructured":"Buckheit, R. W. 3rd, Salgado, M., Silciano, R. F. & Blankson, J. N. Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors. J. Virol. 86, 13679\u201313688, https:\/\/doi.org\/10.1128\/JVI.02439-12 (2012).","journal-title":"J. Virol."},{"key":"58696_CR45","doi-asserted-by":"publisher","first-page":"ofu117","DOI":"10.1093\/ofid\/ofu117","volume":"2","author":"JZ Li","year":"2015","unstructured":"Li, J. Z. et al. Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics. Open. forum Infect. Dis. 2, ofu117, https:\/\/doi.org\/10.1093\/ofid\/ofu117 (2015).","journal-title":"Open. forum Infect. Dis."},{"key":"58696_CR46","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/infdis\/jiy331","volume":"218","author":"A Lidofsky","year":"2018","unstructured":"Lidofsky, A. et al. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus\/Hepatitis C Virus Coinfection. J. Infect. Dis. 218, 1394\u20131403, https:\/\/doi.org\/10.1093\/infdis\/jiy331 (2018).","journal-title":"J. Infect. Dis."},{"key":"58696_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/524143","volume":"197","author":"PW Hunt","year":"2008","unstructured":"Hunt, P. W. et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197, 126\u2013133 (2008).","journal-title":"J. Infect. Dis."},{"key":"58696_CR48","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3389\/fimmu.2018.01576","volume":"9","author":"FH Cortes","year":"2018","unstructured":"Cortes, F. H. et al. Plasmatic levels of IL-18, IP-10, and activated CD8(+) T cells are potential biomarkers to identify HIV-1 elite controllers with a true functional cure profile. Front. Immunol. 9, 1576, https:\/\/doi.org\/10.3389\/fimmu.2018.01576 (2018).","journal-title":"Front. Immunol."},{"key":"58696_CR49","doi-asserted-by":"publisher","first-page":"e1004930","DOI":"10.1371\/journal.ppat.1004930","volume":"11","author":"E Martin-Gayo","year":"2015","unstructured":"Martin-Gayo, E. et al. Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers. PLoS Pathog. 11, e1004930, https:\/\/doi.org\/10.1371\/journal.ppat.1004930 (2015).","journal-title":"PLoS Pathog."},{"key":"58696_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.0902-4441.2003.00199.x","volume":"72","author":"LR Bisset","year":"2004","unstructured":"Bisset, L. R., Lung, T. L., Kaelin, M., Ludwig, E. & Dubs, R. W. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur. J. Haematol. 72, 203\u2013212, https:\/\/doi.org\/10.1046\/j.0902-4441.2003.00199.x (2004).","journal-title":"Eur. J. Haematol."},{"key":"58696_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coviro.2019.05.010","volume":"38","author":"C Lopez-Galindez","year":"2019","unstructured":"Lopez-Galindez, C., Pernas, M., Casado, C., Olivares, I. & Lorenzo-Redondo, R. Elite controllers and lessons learned for HIV-1 cure. Curr. Opin. virology 38, 31\u201336, https:\/\/doi.org\/10.1016\/j.coviro.2019.05.010 (2019).","journal-title":"Curr. Opin. virology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58696-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T14:59:46Z","timestamp":1672671586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58696-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58696"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58696-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,5]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1902"}}